Santen Pharmaceutical Co (SNPHY) Ratios

5 Followers

Santen Pharmaceutical Co Ratios

SNPHY's free cash flow for Q4 2025 was ¥0.60. For the 2025 fiscal year, SNPHY's free cash flow was decreased by ¥ and operating cash flow was ¥0.18. See a summary of the company’s cash flow.

Ratios	TTM	Mar 26	Mar 26	Mar 25	Mar 24
Liquidity Ratios
Current Ratio	―	2.58	2.60	2.54	2.38
Quick Ratio	―	1.99	1.87	2.08	1.94
Cash Ratio	―	1.07	0.92	1.02	0.65
Solvency Ratio	―	0.36	0.46	0.34	0.02
Operating Cash Flow Ratio	―	0.70	0.52	0.78	0.42
Short-Term Operating Cash Flow Coverage	―	222.36	13.00	1.35K	151.62
Net Current Asset Value	¥ ―	¥ 100.20B	¥ 102.18B	¥ 105.81B	¥ 85.44B
Leverage Ratios
Debt-to-Assets Ratio	―	0.08	0.08	0.08	0.09
Debt-to-Equity Ratio	―	0.12	0.12	0.11	0.12
Debt-to-Capital Ratio	―	0.11	0.10	0.10	0.11
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.08	0.00
Financial Leverage Ratio	―	1.43	1.42	1.42	1.43
Debt Service Coverage Ratio	―	15.85	10.05	17.49	2.16
Interest Coverage Ratio	―	17.26	22.68	14.47	-2.06
Debt to Market Cap	―	<0.01	<0.01	0.05	<0.01
Interest Debt Per Share	―	105.98	112.99	103.09	97.33
Net Debt to EBITDA	―	-1.00	-0.69	-1.17	-1.68
Profitability Margins
Gross Profit Margin	―	57.01%	55.20%	59.18%	59.52%
EBIT Margin	―	16.73%	15.50%	10.78%	-1.54%
EBITDA Margin	―	19.67%	21.80%	16.80%	4.64%
Operating Profit Margin	―	15.63%	15.50%	12.76%	-1.11%
Pretax Profit Margin	―	15.83%	16.27%	9.89%	-2.08%
Net Profit Margin	―	12.09%	12.81%	8.82%	-5.36%
Continuous Operations Profit Margin	―	11.95%	12.88%	8.84%	-5.37%
Net Income Per EBT	―	76.36%	78.77%	89.18%	257.77%
EBT Per EBIT	―	101.28%	104.93%	77.51%	187.67%
Return on Assets (ROA)	―	8.86%	9.33%	6.11%	-3.55%
Return on Equity (ROE)	―	12.67%	13.28%	8.70%	-5.08%
Return on Capital Employed (ROCE)	―	14.54%	14.24%	11.24%	-0.93%
Return on Invested Capital (ROIC)	―	10.87%	11.16%	9.97%	-0.92%
Return on Tangible Assets	―	10.86%	11.23%	7.57%	-4.60%
Earnings Yield	―	7.32%	6.85%	5.11%	-3.44%
Efficiency Ratios
Receivables Turnover	―	4.18	4.29	3.34	2.60
Payables Turnover	―	3.31	3.90	2.83	2.51
Inventory Turnover	―	2.50	2.14	2.85	2.87
Fixed Asset Turnover	―	4.11	3.94	4.22	4.22
Asset Turnover	―	0.73	0.73	0.69	0.66
Working Capital Turnover Ratio	―	2.14	2.22	2.26	2.17
Cash Conversion Cycle	―	122.97	162.52	108.41	122.11
Days of Sales Outstanding	―	87.31	85.16	109.44	140.18
Days of Inventory Outstanding	―	146.00	170.90	127.88	127.17
Days of Payables Outstanding	―	110.34	93.54	128.91	145.24
Operating Cycle	―	233.30	256.06	237.32	267.35
Cash Flow Ratios
Operating Cash Flow Per Share	―	174.78	140.78	198.01	95.88
Free Cash Flow Per Share	―	155.67	118.63	168.88	32.42
CapEx Per Share	―	19.11	22.15	29.13	63.47
Free Cash Flow to Operating Cash Flow	―	0.89	0.84	0.85	0.34
Dividend Paid and CapEx Coverage Ratio	―	3.25	2.23	3.22	1.00
Capital Expenditure Coverage Ratio	―	9.15	6.36	6.80	1.51
Operating Cash Flow Coverage Ratio	―	1.78	1.32	2.07	1.03
Operating Cash Flow to Sales Ratio	―	0.20	0.15	0.24	0.13
Free Cash Flow Yield	―	10.96%	6.72%	11.89%	2.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	13.66	14.53	19.57	-29.10
Price-to-Sales (P/S) Ratio	―	1.65	1.87	1.73	1.56
Price-to-Book (P/B) Ratio	―	1.73	1.94	1.70	1.48
Price-to-Free Cash Flow (P/FCF) Ratio	―	9.12	14.88	8.41	34.64
Price-to-Operating Cash Flow Ratio	―	8.12	12.54	7.18	11.71
Price-to-Earnings Growth (PEG) Ratio	―	0.32	0.87	-0.07	0.19
Price-to-Fair Value	―	1.73	1.94	1.70	1.48
Enterprise Value Multiple	―	7.39	7.89	9.11	31.92
Enterprise Value	―	436.26B	531.89B	461.88B	413.33B
EV to EBITDA	―	7.39	7.89	9.11	31.92
EV to Sales	―	1.45	1.72	1.53	1.48
EV to Free Cash Flow	―	8.04	13.68	7.45	32.91
EV to Operating Cash Flow	―	7.16	11.53	6.36	11.13
Tangible Book Value Per Share	―	601.58	687.78	603.86	508.46
Shareholders’ Equity Per Share	―	821.11	910.43	834.19	758.81
Tax and Other Ratios
Effective Tax Rate	―	0.24	0.21	0.11	-1.58
Revenue Per Share	―	860.58	943.80	823.04	720.24
Net Income Per Share	―	104.00	120.94	72.62	-38.58
Tax Burden	―	0.76	0.79	0.89	2.58
Interest Burden	―	0.95	1.05	0.92	1.35
Research & Development to Revenue	―	0.08	0.09	0.08	0.10
SG&A to Revenue	―	0.29	0.31	0.30	0.34
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	1.68	1.16	2.73	-2.48

Currency in JPY